Guardant Health Reports on Shareholder Vote

Ticker: GH · Form: 8-K · Filed: 2025-06-20T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

TL;DR

Guardant Health held a shareholder vote on June 18th.

AI Summary

Guardant Health, Inc. filed an 8-K on June 20, 2025, reporting on matters submitted to a vote of its security holders on June 18, 2025. The filing details the company's corporate structure and its principal executive offices located at 3100 Hanover Street, Palo Alto, California.

Why It Matters

This filing indicates a formal process of shareholder engagement and decision-making, which is a standard corporate governance event.

Risk Assessment

Risk Level: low — This is a routine corporate filing regarding a shareholder vote, not indicating any immediate financial or operational risks.

Key Numbers

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Guardant Health's security holders on June 18, 2025?

The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in this excerpt.

What is the primary business of Guardant Health, Inc. according to the SIC code?

Guardant Health, Inc. is classified under SERVICES-MEDICAL LABORATORIES [8071].

When was Guardant Health, Inc. incorporated or organized?

Guardant Health, Inc. was incorporated or organized in Delaware.

What is the fiscal year end for Guardant Health, Inc.?

The fiscal year end for Guardant Health, Inc. is December 31st.

What is the telephone number for Guardant Health, Inc.'s principal executive offices?

The telephone number is 855-698-8887.

From the Filing

0001193125-25-143681.txt : 20250620 0001193125-25-143681.hdr.sgml : 20250620 20250620162211 ACCESSION NUMBER: 0001193125-25-143681 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250618 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250620 DATE AS OF CHANGE: 20250620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 251061673 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 8-K 1 d47878d8k.htm 8-K 8-K false 0001576280 0001576280 2025-06-18 2025-06-18     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 18, 2025     GUARDANT HEALTH, INC. (Exact name of registrant as specified in its charter)       Delaware   001-38683   45-4139254 (State or other jurisdiction of incorporation or organization)   (Commission File Number)   (IRS Employer Identification No.) 3100 Hanover Street Palo Alto , California 94304 (Address of principal executive offices) (Zip Code) 855 - 698-8887 (Registrant’s telephone number, include area code)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.00001 par value per share   GH   The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.07. Submission of Matters to a Vote of Security Holders. The annual meeting of stockholders (the “Annual Meeting”) of Guardant Health, Inc. (the “Company”) was held on June 18, 2025. All of the nominees for director listed in Proposal 1 in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 29, 2025 (the “Proxy Statement”), were elected to serve on the Company’s board of directors by the following vote:   Name of Nominee    Votes For      Votes Withheld      Broker Non-Votes   Vijaya Gadde      95,987,234        2,587,247     

View on Read The Filing